ACC1-expressing pathogenic T helper 2 cell populations facilitate lung and skin inflammation in mice

  • J Exp Med. 2021 Dec 6;218(12):e20210639. doi: 10.1084/jem.20210639.
Takahiro Nakajima  1 Toshio Kanno  1 Satoru Yokoyama  1 Shigemi Sasamoto  1 Hikari K Asou  1 Damon J Tumes  2 Osamu Ohara  3 Toshinori Nakayama  4  5 Yusuke Endo  1  6
Affiliations
  • 1. Department of Frontier Research and Development, Laboratory of Medical Omics Research, Kazusa DNA Research Institute, Chiba, Japan.
  • 2. Centre for Cancer Biology, University of South Australia, North Terrace, Adelaide, Australia.
  • 3. Department of Applied Genomics Kazusa DNA Research Institute, Chiba, Japan.
  • 4. Department of Immunology, Graduate School of Medicine, Chiba University, Chiba, Japan.
  • 5. AMED-CREST, AMED, Chiba, Japan.
  • 6. Department of Omics Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.
Abstract

T cells possess distinguishing effector functions and drive inflammatory disorders. We have previously identified IL-5-producing Th2 cells as the pathogenic population predominantly involved in the pathology of allergic inflammation. However, the cell-intrinsic signaling pathways that control the pathogenic Th2 cell function are still unclear. We herein report the high expression of Acetyl-CoA Carboxylase 1 (ACC1) in the pathogenic CD4+ T cell population in the lung and skin. The genetic deletion of CD4+ T cell-intrinsic ACC1 dampened eosinophilic and basophilic inflammation in the lung and skin by constraining IL-5 or IL-3 production. Mechanistically, ACC1-dependent fatty acid biosynthesis induces the pathogenic cytokine production of CD4+ T cells via metabolic reprogramming and the availability of acetyl-CoA for epigenetic regulation. We thus identified a distinct phenotype of the pathogenic T cell population in the lung and skin, and ACC1 was shown to be an essential regulator controlling the pathogenic function of these populations to promote type 2 inflammation.

Products